Demeng Chen
- Cancer Research top 1%
- Cancer-related molecular mechanisms research 6
- Molecular Biology top 5%
- RNA modifications and cancer 18
- Cancer-related gene regulation 12
- Epigenetics and DNA Methylation 10
- Ubiquitin and proteasome pathways 5
- Urology top 2%
- Oncology top 5%
- Cancer Cells and Metastasis 11
- Cancer Immunotherapy and Biomarkers 6
- Rehabilitation top 5%
-
- HVDC Systems and Fault Protection 7
Demeng Chen
71 papers receiving 3.2k citations
Hit Papers
Peers
Comparison fields: 5 of 120
- Cancer Research 1.1k
- Molecular Biology 2.4k
- Urology 215
- Oncology 603
- Rehabilitation 104
Countries citing papers authored by Demeng Chen
This map shows the geographic impact of Demeng Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Demeng Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Demeng Chen more than expected).
Fields of papers citing papers by Demeng Chen
This network shows the impact of papers produced by Demeng Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Demeng Chen. The network helps show where Demeng Chen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Demeng Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 6 | |
| 4 | 2024 | 6 | |
| 5 | 2024 | 4 | |
| 6 | 2024 | 7 | |
| 7 | 2024 | 14 | |
| 8 | 2024 | 11 | |
| 9 | 2024 | 6 | |
| 10 | 2023 | 5 | |
| 11 | 2023 | 7 | |
| 12 | 2023 | 6 | |
| 13 | 2022 | 133 | |
| 14 | 2022 | 19 | |
| 15 | 2022 | 1 | |
| 16 | 2021 | 66 | |
| 17 | 2021 | 59 | |
| 18 | 2021 | 90 | |
| 19 | 2017 | 222 | |
| 20 | 2016 | 40 |
About Demeng Chen
Demeng Chen is a scholar working on Oncology, Cancer Research and Molecular Biology, having authored 74 papers that have together received 3.2k indexed citations. Recurring topics across this work include RNA modifications and cancer (18 papers), Cancer-related gene regulation (12 papers), Cancer Cells and Metastasis (11 papers), Epigenetics and DNA Methylation (10 papers), HVDC Systems and Fault Protection (7 papers), Cancer-related molecular mechanisms research (6 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Ubiquitin and proteasome pathways (5 papers). The work is most often cited by research in Cancer Research (1.1k citations), Molecular Biology (2.4k citations) and Urology (215 citations). Demeng Chen has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Radhika P. Atit, Cun‐Yu Wang, Andrew Jarrell, Richard A. Lang, Maosheng Cheng, Zhixiang Zuo, Xingyang Li, Tiebang Kang, Rui‐Hua Xu and Huai‐Qiang Ju. Their work appears in journals such as International Journal of Oral Science, Oral Diseases, Journal of Clinical Investigation, Molecular Therapy and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.